
Login
Who's Online
We have 159 guests and no members online
Statistics
- Users 5563
- Articles 750
- Articles View Hits 17644195
Why Use This Site for Advertisement?
Thank you for your interest in advertising on Gene Therapy Net. The website is active since January 2008 and the site's traffic grows day by day (see statistics). The visitors of Gene Therapy Net are professionals, doctors and researchers, as well as students, patients, regulatory affairs officers, government policy officers, and everyone else interested in gene therapy. |
|
Gene Therapy Net is run by a policy officer in the clinical gene therapy trial assessment procedure in the Netherlands. He has a scientific background in molecular biology and immunology. The website is a non-governmental, personal initiative and is aimed to provide comprehensive and accurate information about gene therapy, clinical trials, research news, and relevant gene therapy regulation and legislation. |
Advertisement Opportunities
Full banners, cube banners and text ads will be placed on highly visible sections throughout the site. Cube banners and text ads are placed in the left columns of the site, whereas full banners are placed in the middle wide column of the site. Your banner or text ad will be hyperlinked to the web address of your choice.
There are four different types of campaigns:
1 | Full banner | Located in rotation with other banners on all pages, including the home page |
2 | Home page banner or text links | Located only on the home page. Always visible in 1st or 2nd news item in center of the home page |
3 | Cube banner | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
4 | Text links | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
Advertisement Rates
We suggest a minimum of 3 months or at least 10,000 impressions, but please keep in mind that these rates and time lengths are not set in stone, but rather displayed to give you an idea on how our ad pricing is usually structured. By advertising on Gene Therapy Net, you agree to our terms and conditions listed below.
Contact us for more information about advertising.
Advertising Terms and Conditions: All ads are reviewed for correct usage, and must be approved prior to publication. Gene Therapy Net reserves the right to refuse advertising privileges to any web site for any reason, including the promotion of pornographic products and/or content, the advocating of illegal activities, immoral conduct, plagiarism, cheating, etc. Gene Therapy Net shall not be held responsible for grammatical errors, typographical errors, or errors in artwork provided by the advertiser. All ads are at the discretion of Gene Therapy Net. All rates are agreed on before advertisement is placed. Your ad will be place after full payment has been received. When an order has been received and payment taken for the service there will be no refund to the advertiser. Gene Therapy Net reserves the right to modify, change or otherwise improve upon the design and format of any or all of its pages at any time without notice. Gene Therapy Net reserves the right to modify, eradicate and/or change any or all of these terms and conditions without notice, including the right to change the above rates or to terminate this advertising program. We appreciate, but do not require, reciprocal links to Gene Therapy Net to be posted on your site.
Suggestions
Gene Therapy News
- How a custom-made gene therapy could save one baby's life - SBS Australia
Sat, 17 May 2025 04:35:0 GMT - Ben Samelson-Jones, MD, PhD, on Conservative Management Following Treatment With DMD Gene Therapy Elevidys - CGTLive®
Sat, 17 May 2025 02:11:0 GMT - First Successful Gene Therapy Patient Is Nine Months Old - WBOC TV
Fri, 16 May 2025 23:50:0 GMT - At gene therapy meeting, no one wants to talk about the Vinay Prasad (not) in the room - statnews.com
Fri, 16 May 2025 23:36:2 GMT - Rocket’s PKP2-Arrhythmogenic Cardiomyopathy Gene Therapy RP-A601 Improves or Stabilizes Heart Function in Phase 1 Trial - CGTLive®
Fri, 16 May 2025 23:35:4 GMT - Rocket plans pivotal trial for cardiac gene therapy, but concerns linger on accelerated pathway - FirstWord Pharma
Fri, 16 May 2025 22:20:3 GMT - Sarepta seeks to expand Duchenne gene therapy Elevidys use to toddlers - Endpoints News
Fri, 16 May 2025 21:50:0 GMT - Rocket Pharma's Gene Therapy Shows Promise in ACM Patients, Says Analyst - Benzinga
Fri, 16 May 2025 21:46:2 GMT - Baby with CPS1 thrives after groundbreaking gene therapy - Motherly
Fri, 16 May 2025 21:29:5 GMT - Personalized Gene Therapy Saves Infant With Formerly 'Incurable' Disorder - extremetech.com
Fri, 16 May 2025 21:12:5 GMT - US Baby Becomes First to Undergo Successful Personalized Gene Therapy - GreekReporter.com
Fri, 16 May 2025 21:05:1 GMT - ASGCT: Neurogene details new safety measures after young patient's death in AAV gene therapy trial - Fierce Biotech
Fri, 16 May 2025 20:17:0 GMT - Eli Lilly strikes $1.3bn gene therapy deal with Rznomics - Pharmaceutical Technology
Fri, 16 May 2025 18:57:0 GMT - Lower attendance at cell and gene therapy conference mirrors challenged industry - Endpoints News
Fri, 16 May 2025 18:33:0 GMT - Duchenne muscular dystrophy gene therapy demonstrates improved motor functions - Contemporary Pediatrics
Fri, 16 May 2025 18:17:3 GMT